Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Standard BioTools Inc. on the transaction, and Fenwick & West advised SomaLogic, Inc. Standard BioTools Inc. (Nasdaq: LAB) and SomaLogic (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Fenwick advised Paragraf on the deal. Paragraf, a producer graphene electronics using transfer-free graphene and standard semiconductor processes, announced its acquisition of Cardea Bio, a producer of...
You must be a Standard 1 Year member to access this content.
Fenwick advised Shockwave Medical, Inc. on the deal. Shockwave Medical, Inc. (NASDAQ: SWAV), a medical device company focused on the development of Intravascular Lithotripsy (IVL) to...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Impel NeuroPharma on the deal. Impel NeuroPharma, a late-stage pharmaceutical company developing transformative therapies for diseases of the central nervous system, announced its...
You must be a Standard 1 Year member to access this content.
